First Trust Advisors LP Organon & Co. Transaction History

First Trust Advisors LP

$95 Billion
Q2 2024

A detailed history of First Trust Advisors LP transactions in Organon & Co. stock. As of the latest transaction made, First Trust Advisors LP holds 1,274,977 shares of OGN stock, worth $24.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,274,977

Previous 953,292 33.74%

Holding current value

$24.4 Million

Previous $17.9 Million 47.27%

% of portfolio

0.03%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.45 - $21.96 $5.61 Million - $7.06 Million	321,685 Added 33.74%	1,274,977 $26.4 Million
Q1 2024 May 13, 2024	SELL	$13.78 - $18.8 $1.58 Million - $2.16 Million	-114,832 Reduced 10.75%	953,292 $17.9 Million
Q4 2023 Feb 13, 2024	BUY	$10.95 - $17.32 $3.85 Million - $6.09 Million	351,518 Added 49.05%	1,068,124 $15.4 Million
Q3 2023 Nov 13, 2023	SELL	$16.59 - $23.77 $3.52 Million - $5.04 Million	-211,904 Reduced 22.82%	716,606 $12.4 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $1.76 Million - $2.25 Million	91,176 Added 10.89%	928,510 $19.3 Million
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $1.93 Million - $2.9 Million	-90,270 Reduced 9.73%	837,334 $19.7 Million
Q4 2022 Feb 09, 2023	BUY	$23.31 - $28.61 $5.42 Million - $6.66 Million	232,703 Added 33.49%	927,604 $25.9 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $15.4 Million - $22.5 Million	-657,690 Reduced 48.62%	694,901 $16.3 Million
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $7.34 Million - $9.02 Million	231,835 Added 20.69%	1,352,591 $45.7 Million
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $13.9 Million - $18 Million	456,966 Added 68.84%	1,120,756 $39.1 Million
Q4 2021 Feb 08, 2022	BUY	$28.67 - $37.13 $19 Million - $24.6 Million	663,790 New	663,790 $20.2 Million

Others Institutions Holding OGN

# of Institutions

795

Shares Held

191M

Call Options Held

1.59M

Put Options Held

931K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.87B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Organon & Co. Transaction History